# Intra-pemetrexed Alone or Combined With Concurrent Radiotherapy for Leptomeningeal Metastasis

> **NCT05305885** · NA · UNKNOWN · sponsor: **The First Hospital of Jilin University** · enrollment: 100 (estimated)

## Conditions studied

- Leptomeningeal Metastasis

## Interventions

- **DRUG:** Pemetrexed
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT05305885
- **Lead sponsor:** The First Hospital of Jilin University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-19
- **Primary completion:** 2023-10
- **Final completion:** 2024-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-09-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05305885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05305885, "Intra-pemetrexed Alone or Combined With Concurrent Radiotherapy for Leptomeningeal Metastasis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05305885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*